Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Nuclear Medicine Radioisotopes Market Report 2024

Nuclear Medicine Radioisotopes Global Market Report 2025 – By Type (Technetium-99m (Tc-99m), Thallium-201 (Tl-20–, Iodine (I-12, Fluorine-18, Rubidium-82 (Rb-8, Iodine-131 (I-13–, Lutetium-177 (Lu-177), Radium-223 (Ra-22, And Alpharadin, Actinium-225 (Ac-22, Other Types), By Application (Oncology, Cardiology, Thyroid, Neurology, Other Applications), By End-User (Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Nuclear Medicine Radioisotopes Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Nuclear Medicine Radioisotopes Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Nuclear Medicine Radioisotopes Market Definition

Nuclear medicine radioisotopes are radioactive isotopes used in nuclear medicine to diagnose, treat, and research various medical conditions. These isotopes emit radiation detected and imaged by specialized equipment or deliver therapeutic doses of radiation to targeted tissues. Nuclear medicine radioisotopes are essential in modern medical diagnostics and treatments, providing critical information and therapeutic options that improve patient outcomes.

The main types of nuclear medicine radioisotopes are technetium-99m (Tc-99m), thallium-201 (Tl-201), iodine (I-123), fluorine-18, rubidium-82 (Rb-82), iodine-131 (I-131), lutetium-177 (Lu-177), radium-223 (Ra-223) and alpharadin, actinium-225 (Ac-225), and others. Technetium-99m (Tc-99m) is a radioactive isotope widely used in nuclear medicine imaging procedures to diagnose various medical conditions. Applications such as oncology, cardiology, Thyroid, neurology, and others for end users such as hospitals, diagnostic centers, specialty clinics, education and research institutes, and others.

Nuclear Medicine Radioisotopes Market Segmentation

The nuclear medicine radioisotopes market covered in this report is segmented –

1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types

2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users

Subsegments:

1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)

2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging

3) By Iodine-123 (I-123): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)

4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging

5) By Rubidium-82 (Rb-82): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging

6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment

7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment

8) By Radium-223 (Ra-223): Ra-223 Dichloride (Xofigo)

9) By Alpharadin (Radium-223 Alpha Emitters): Alpharadin For Bone Metastasis Treatment

10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)

Nuclear Medicine Radioisotopes Market Size and growth rate 2025 to 2029: Graph

Nuclear Medicine Radioisotopes Market Size 2025 And Growth Rate

The nuclear medicine radioisotopes market size has grown strongly in recent years. It will grow from $8.21 billion in 2024 to $8.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to discovery of radioactivity, emergence of nuclear medicine, therapeutic applications, clinical research, and patient demand.

Nuclear Medicine Radioisotopes Market Growth Forecast

The nuclear medicine radioisotopes market size is expected to see strong growth in the next few years. It will grow to $12.4 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing healthcare spending, expansion of healthcare infrastructure, growing awareness of environmental sustainability, education campaigns and awareness programs and growth in medical tourism. Major trends in the forecast period include development of new radioisotopes, production and supply chain innovations, microfluidics and lab-on-a-chip technology, artificial intelligence in radiopharmaceutical development and nanotechnology.

Book your 30 minutes free consultation with our research experts

Contact Us

Nuclear Medicine Radioisotopes Market Driver: Rising Cases Of Cardiovascular Diseases Is Driving The Growth Of The Nuclear Medicine Radioisotopes

The rising cases of cardiovascular diseases are expected to propel the growth of the nuclear medicine radioisotope market going forward. Cardiovascular diseases refer to a group of diseases that affect the heart and blood vessels. The rising cases of cardiovascular diseases are due to sedentary lifestyles, poor dietary habits, increasing rates of obesity, and aging populations. The nuclear medicine radioisotopes are invaluable in diagnosing, evaluating, and managing cardiovascular diseases with detailed insights into cardiac function, perfusion, and tissue viability, which are essential for accurate diagnosis and effective treatment planning. For instance, in September 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the rising cases of cardiovascular diseases are driving the growth of the nuclear medicine radioisotope market.

Global Nuclear Medicine Radioisotopes Market Major Players

Major companies operating in the nuclear medicine radioisotopes market are Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczacibasi-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation

Global Nuclear Medicine Radioisotopes Market Trend: Technological Advancement To Drive Innovation In The Nuclear Medicine Radioisotopes

Major companies operating in the nuclear medicine radioisotopes market are focusing on developing innovative products, such as the compact low-energy cyclotron, to improve the production and availability of radioisotopes, ensuring more efficient and accessible diagnostic and therapeutic options. A compact, low-energy cyclone is a small particle accelerator used to create radioisotopes for medical imaging and treatments in nuclear medicine. For instance, in January 2022, IBA, a Belgium-based provider of radiopharmaceutical production solutions, launched Cyclone Key, a new accelerator providing increased access to diagnostic solutions and enabling in-house production of radiopharmaceuticals. This innovative solution offers unique features such as a compact and efficient design, fully automated operation, multiple isotope production capabilities, ease of installation and operation, water cooling, self-shielding, and high performance, making IT versatile and reliable.

Nuclear Medicine Radioisotopes Market Merger And Acquisition: Telix Pharmaceuticals Acquired ARTMS To Enhance Capabilities In Nuclear Medicine

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS for an undisclosed amount. With this acquisition, Telix Pharmaceuticals aimed to strengthen its nuclear medicine capabilities, optimize production procedures, and broaden its range of diagnostic and therapeutic radiopharmaceuticals. ARTMS is a Canada-based company providing novel radioisotope technology and is involved in nuclear medicine radioisotopes.

Regional Outlook For The Global Nuclear Medicine Radioisotopes Market

North America was the largest region in the nuclear medicine radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nuclear medicine radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nuclear Medicine Radioisotopes Market?

The nuclear medicine radioisotopes market consists of sales of yttrium-90, indium-111, carbon-11, samarium-153, and strontium-89. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nuclear Medicine Radioisotopes Industry?

The nuclear medicine radioisotopes research report is one of a series of new reports from The Business Research Company that provides nuclear medicine radioisotopes market statistics, including the nuclear medicine radioisotopes industry's global market size, regional shares, competitors with a nuclear medicine radioisotopes market share, detailed nuclear medicine radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine radioisotopes industry. This nuclear medicine radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Nuclear Medicine Radioisotopes Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $8.94 billion
Revenue Forecast In 2034 $12.4 billion
Growth Rate CAGR of 8.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-12
3), Fluorine-18, Rubidium-82 (Rb-8
2), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-22
3) And Alpharadin, Other Types
2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users Subsegments: 1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)
2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging
3) By Iodine-123 (I-12
3): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)
4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging
5) By Rubidium-82 (Rb-8
2): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging 6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment 7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment 8) By Radium-223 (Ra-22
3): Ra-223 Dichloride (Xofigo) 9) By Alpharadin (Radium-223 Alpha Emitters): Alpharadin For Bone Metastasis Treatment 10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-6
4), Yttrium-90 (Y-90)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczacibasi-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Nuclear Medicine Radioisotopes Market Characteristics

    3. Nuclear Medicine Radioisotopes Market Trends And Strategies

    4. Nuclear Medicine Radioisotopes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Nuclear Medicine Radioisotopes Growth Analysis And Strategic Analysis Framework

    5.1. Global Nuclear Medicine Radioisotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Nuclear Medicine Radioisotopes Market Growth Rate Analysis

    5.4. Global Nuclear Medicine Radioisotopes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Nuclear Medicine Radioisotopes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Nuclear Medicine Radioisotopes Total Addressable Market (TAM)

    6. Nuclear Medicine Radioisotopes Market Segmentation

    6.1. Global Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Technetium-99m (Tc-99m)

    Thallium-201 (Tl-201)

    Iodine (I-123)

    Fluorine-18

    Rubidium-82 (Rb-82)

    Iodine-131 (I-131)

    Lutetium-177 (Lu-177)

    Radium-223 (Ra-223) And Alpharadin

    Other Types

    6.2. Global Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oncology

    Cardiology

    Thyroid

    Neurology

    Other Applications

    6.3. Global Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Diagnostic Centers

    Specialty Clinics

    Education And Research Institutes

    Other End-Users

    6.4. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Technetium-99m (Tc-99m), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Sodium Pertechnetate Tc-99m

    Tc-99m MDP (Methylene Diphosphonate)

    Tc-99m HMPAO (Hexamethylpropyleneamine oxime)

    6.5. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Thallium-201 (Tl-201), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Thallous Chloride Tl-201

    Thallium-201 for Cardiac Imaging

    6.6. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-123 (I-123), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Iodine-123 Sodium Iodide

    Iodine-123 Ioflupane (DaTscan)

    6.7. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Fluorine-18, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    FDG (Fluorodeoxyglucose) F-18

    Fluoride-18 For Bone Imaging

    6.8. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Rubidium-82 (Rb-82), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Rb-82 For PET (Positron Emission Tomography) Imaging

    Rb-82 For Cardiac Imaging

    6.9. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-131 (I-131), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    I-131 Sodium Iodide

    I-131 For Thyroid Cancer Treatment

    I-131 For Hyperthyroidism Treatment

    6.10. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Lutetium-177 (Lu-177), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Lu-177-DOTATATE

    Lu-177 For Prostate Cancer Treatment

    6.11. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Radium-223 (Ra-223), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ra-223 Dichloride (Xofigo)

    6.12. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Alpharadin (Radium-223 Alpha Emitters), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Alpharadin For Bone Metastasis Treatment

    6.13. Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ac-225 For Targeted Alpha Therapy (TAT)

    Ac-225 For Cancer Treatment

    Gallium-68 (Ga-68)

    Copper-64 (Cu-64)

    Yttrium-90 (Y-90)

    7. Nuclear Medicine Radioisotopes Market Regional And Country Analysis

    7.1. Global Nuclear Medicine Radioisotopes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Nuclear Medicine Radioisotopes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Nuclear Medicine Radioisotopes Market

    8.1. Asia-Pacific Nuclear Medicine Radioisotopes Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Nuclear Medicine Radioisotopes Market

    9.1. China Nuclear Medicine Radioisotopes Market Overview

    9.2. China Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Nuclear Medicine Radioisotopes Market

    10.1. India Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Nuclear Medicine Radioisotopes Market

    11.1. Japan Nuclear Medicine Radioisotopes Market Overview

    11.2. Japan Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Nuclear Medicine Radioisotopes Market

    12.1. Australia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Nuclear Medicine Radioisotopes Market

    13.1. Indonesia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Nuclear Medicine Radioisotopes Market

    14.1. South Korea Nuclear Medicine Radioisotopes Market Overview

    14.2. South Korea Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Nuclear Medicine Radioisotopes Market

    15.1. Western Europe Nuclear Medicine Radioisotopes Market Overview

    15.2. Western Europe Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Nuclear Medicine Radioisotopes Market

    16.1. UK Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Nuclear Medicine Radioisotopes Market

    17.1. Germany Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Nuclear Medicine Radioisotopes Market

    18.1. France Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Nuclear Medicine Radioisotopes Market

    19.1. Italy Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Nuclear Medicine Radioisotopes Market

    20.1. Spain Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Nuclear Medicine Radioisotopes Market

    21.1. Eastern Europe Nuclear Medicine Radioisotopes Market Overview

    21.2. Eastern Europe Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Nuclear Medicine Radioisotopes Market

    22.1. Russia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Nuclear Medicine Radioisotopes Market

    23.1. North America Nuclear Medicine Radioisotopes Market Overview

    23.2. North America Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Nuclear Medicine Radioisotopes Market

    24.1. USA Nuclear Medicine Radioisotopes Market Overview

    24.2. USA Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Nuclear Medicine Radioisotopes Market

    25.1. Canada Nuclear Medicine Radioisotopes Market Overview

    25.2. Canada Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Nuclear Medicine Radioisotopes Market

    26.1. South America Nuclear Medicine Radioisotopes Market Overview

    26.2. South America Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Nuclear Medicine Radioisotopes Market

    27.1. Brazil Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Nuclear Medicine Radioisotopes Market

    28.1. Middle East Nuclear Medicine Radioisotopes Market Overview

    28.2. Middle East Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Nuclear Medicine Radioisotopes Market

    29.1. Africa Nuclear Medicine Radioisotopes Market Overview

    29.2. Africa Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Nuclear Medicine Radioisotopes Market Competitive Landscape And Company Profiles

    30.1. Nuclear Medicine Radioisotopes Market Competitive Landscape

    30.2. Nuclear Medicine Radioisotopes Market Company Profiles

    30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. GE HealthCare Technologies Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Nuclear Medicine Radioisotopes Market Other Major And Innovative Companies

    31.1. Mallinckrodt Pharmaceuticals

    31.2. Bracco Imaging S.p.A.

    31.3. Lantheus Holdings Inc.

    31.4. Curium Pharma

    31.5. Australian Nuclear Science and Technology Organisation (ANSTO) Health

    31.6. Eckert & Ziegler Strahlen

    31.7. NorthStar Medical Radioisotopes

    31.8. NTP Radioisotopes

    31.9. Shine Medical Technologies Inc.

    31.10. Jubilant DraxImage Inc.

    31.11. Isotopia Molecular Imaging Ltd.

    31.12. Eczacibasi-Monrol Nuclear Products

    31.13. International Isotopes Inc.

    31.14. Polatom Sp. z o.o.

    31.15. Radiomedix Inc

    32. Global Nuclear Medicine Radioisotopes Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Nuclear Medicine Radioisotopes Market

    34. Recent Developments In The Nuclear Medicine Radioisotopes Market

    35. Nuclear Medicine Radioisotopes Market High Potential Countries, Segments and Strategies

    35.1 Nuclear Medicine Radioisotopes Market In 2029 - Countries Offering Most New Opportunities

    35.2 Nuclear Medicine Radioisotopes Market In 2029 - Segments Offering Most New Opportunities

    35.3 Nuclear Medicine Radioisotopes Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Technetium-99m (Tc-99m), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Thallium-201 (Tl-201), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-123 (I-123), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Fluorine-18, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Rubidium-82 (Rb-82), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-131 (I-131), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Lutetium-177 (Lu-177), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Radium-223 (Ra-223), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Alpharadin (Radium-223 Alpha Emitters), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Nuclear Medicine Radioisotopes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Nuclear Medicine Radioisotopes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Cardinal Health Inc. Financial Performance
  • Table 85: Bayer AG Financial Performance
  • Table 86: Siemens Healthineers AG Financial Performance
  • Table 87: GE HealthCare Technologies Financial Performance
  • Table 88: BWX Technologies Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Technetium-99m (Tc-99m), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Thallium-201 (Tl-201), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-123 (I-123), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Fluorine-18, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Rubidium-82 (Rb-82), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Iodine-131 (I-131), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Lutetium-177 (Lu-177), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Radium-223 (Ra-223), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Alpharadin (Radium-223 Alpha Emitters), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Nuclear Medicine Radioisotopes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Nuclear Medicine Radioisotopes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Nuclear Medicine Radioisotopes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Cardinal Health Inc. Financial Performance
  • Figure 85: Bayer AG Financial Performance
  • Figure 86: Siemens Healthineers AG Financial Performance
  • Figure 87: GE HealthCare Technologies Financial Performance
  • Figure 88: BWX Technologies Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the fertility drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the antivirals market research report 2022 with industry size, share, segments and market growth

Read More

Nuclear Imaging Devices And Equipment Global Market Report 2025 – By Product Type (SPECT Systems, PET Systems, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, Other Applications), By End-User (Hospitals, Imaging Centers, Academic & Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Electricity Global Market Report 2025 – By Reactor Type (Pressurized Water Reactors (PWR), Fast Breeder Reactor (FBR), Pressurized Heavy-Water Reactor (PHWR), Boiling Water Reactor (BWR), Light Water Graphite Reactor (LWGR), Gas-Cooled Reactor (GCR)), By Technology (Generation I, Generation II, Generation III, and Generation IV), By End-User (Residential, Commercial, Industrial) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Power Reactor Decommissioning Global Market Report 2025 – By Reactor Type (Pressurized Water Reactor, Pressurized Heavy Water Reactor, Boiling Water Reactor, High-temperature Gas-cooled Reactor, Liquid Metal Fast Breeder Reactor, Other Reactor Types), By Capacity (Below 100 MW, 100-1000 MW, Above 1000 MW), By Application (Commercial Power Reactor, Prototype Power Reactor, Research Reactor) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Medicine Global Market Report 2025 – By Type (Diagnostic, Therapeutic), By Application (Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application), By End-User (Hospitals and Clinics, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Decommissioning Services Global Market Report 2025 – By Type( Pressurized Water Reactor (PWR), Boiling Water Reactor (BWR), Gas Cooled Reactor (GCR), Other Types), By Capacity( Upto 800 MW, 800 MW-1000 MW, Above 1000 MW), By Application( Immediate Dismantling, Deferred Dismantling, Entombment) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Fusion Global Market Report 2025 – By Technology (Inertial Confinement, Magnetic Confinement), By Fuels (Deuterium, Tritium, Helium-3, Proton Boron) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Medicine Diagnostics Global Market Report 2025 – By Type (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals), By Application (Cardiology, Thyroid, Neurology, Oncology, Other Applications), By End-User (Hospitals And Diagnostic Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Spent Nuclear Fuel Waste Management Global Market Report 2025 – By Type (Low-level Waste, Intermediate-level Waste, High-level Waste), By Disposal Type (Near Surface Disposal, Deep Surface Disposal), By Source (Nuclear Fuel Cycle, Research, Medical, and Industrial Source, Military And Defense Programs), By Application (Boiling Water Reactors, Gas Cooled Reactors, Pressurized Water Reactors, Pressurized Heavy Water Reactors, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Nuclear Medicine Radioisotopes market?

Nuclear medicine radioisotopes are radioactive isotopes used in nuclear medicine to diagnose, treat, and research various medical conditions. These isotopes emit radiation detected and imaged by specialized equipment or deliver therapeutic doses of radiation to targeted tissues. Nuclear medicine radioisotopes are essential in modern medical diagnostics and treatments, providing critical information and therapeutic options that improve patient outcomes. For further insights on the Nuclear Medicine Radioisotopes market, request a sample here

How will the Nuclear Medicine Radioisotopes market drivers and restraints affect the market dynamics? What forces will shape the Nuclear Medicine Radioisotopes industry going forward?

The Nuclear Medicine Radioisotopes market major growth driver - Rising Cases Of Cardiovascular Diseases Is Driving The Growth Of The Nuclear Medicine Radioisotopes. For further insights on the Nuclear Medicine Radioisotopes market, request a sample here

What is the forecast market size or the forecast market value of the Nuclear Medicine Radioisotopes market?

The Nuclear Medicine Radioisotopes market size has grown strongly in recent years. The nuclear medicine radioisotopes market size has grown strongly in recent years. It will grow from $8.21 billion in 2024 to $8.94 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to discovery of radioactivity, emergence of nuclear medicine, therapeutic applications, clinical research, and patient demand. The nuclear medicine radioisotopes market size is expected to see strong growth in the next few years. It will grow to $12.4 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing healthcare spending, expansion of healthcare infrastructure, growing awareness of environmental sustainability, education campaigns and awareness programs and growth in medical tourism. Major trends in the forecast period include development of new radioisotopes, production and supply chain innovations, microfluidics and lab-on-a-chip technology, artificial intelligence in radiopharmaceutical development and nanotechnology. For further insights on the Nuclear Medicine Radioisotopes market, request a sample here

How is the Nuclear Medicine Radioisotopes market segmented?

The nuclear medicine radioisotopes market covered in this report is segmented –
1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types
2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users
Subsegments:
1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)
2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging
3) By Iodine-123 (I-123): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)
4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging
5) By Rubidium-82 (Rb-82): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging
6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment
7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment
8) By Radium-223 (Ra-223): Ra-223 Dichloride (Xofigo)
9) By Alpharadin (Radium-223 Alpha Emitters): Alpharadin For Bone Metastasis Treatment
10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90) For further insights on the Nuclear Medicine Radioisotopes market, request a sample here

Which region has the largest share of the Nuclear Medicine Radioisotopes market? What are the other regions covered in the report?

North America was the largest region in the nuclear medicine radioisotopes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Nuclear Medicine Radioisotopes market, request a sample here.

Who are the major players in the Nuclear Medicine Radioisotopes market?

Major companies operating in the nuclear medicine radioisotopes market are focusing on developing innovative products, such as the compact low-energy cyclotron, to improve the production and availability of radioisotopes, ensuring more efficient and accessible diagnostic and therapeutic options. A compact, low-energy cyclone is a small particle accelerator used to create radioisotopes for medical imaging and treatments in nuclear medicine. For instance, in January 2022, IBA, a Belgium-based provider of radiopharmaceutical production solutions, launched Cyclone Key, a new accelerator providing increased access to diagnostic solutions and enabling in-house production of radiopharmaceuticals. This innovative solution offers unique features such as a compact and efficient design, fully automated operation, multiple isotope production capabilities, ease of installation and operation, water cooling, self-shielding, and high performance, making it versatile and reliable.. For further insights on the Nuclear Medicine Radioisotopes market, request a sample here.

What are the key trends in the Nuclear Medicine Radioisotopes market?

Major trends in the Nuclear Medicine Radioisotopes market include Technological Advancement To Drive Innovation In The Nuclear Medicine Radioisotopes. For further insights on the Nuclear Medicine Radioisotopes market, request a sample here.

What are the major opportunities in the Nuclear Medicine Radioisotopes market? What are the strategies for the Nuclear Medicine Radioisotopes market?

For detailed insights on the major opportunities and strategies in the Nuclear Medicine Radioisotopes market, request a sample here.

How does the Nuclear Medicine Radioisotopes market relate to the overall economy and other similar markets?

For detailed insights on Nuclear Medicine Radioisotopes's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Nuclear Medicine Radioisotopes industry?

For detailed insights on the mergers and acquisitions in the Nuclear Medicine Radioisotopes industry, request a sample here.

What are the key dynamics influencing the Nuclear Medicine Radioisotopes market growth? SWOT analysis of the Nuclear Medicine Radioisotopes market.

For detailed insights on the key dynamics influencing the Nuclear Medicine Radioisotopes market growth and SWOT analysis of the Nuclear Medicine Radioisotopes industry, request a sample here.